Driehaus Capital Management LLC Neurocrine Biosciences Inc Transaction History

Driehaus Capital Management LLC

$10.3 Billion
Q4 2024

A detailed history of Driehaus Capital Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Driehaus Capital Management LLC holds 102,921 shares of NBIX stock, worth $12.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

102,921

Previous 70,807 45.35%

Holding current value

$12.3 Million

Previous $8.15 Million 72.33%

% of portfolio

0.14%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$111.62 - $139.44 $3.58 Million - $4.48 Million	32,114 Added 45.35%	102,921 $14 Million
Q3 2024 Nov 14, 2024	SELL	$114.58 - $153.15 $55,915 - $74,737	-488 Reduced 0.68%	70,807 $8.15 Million
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $38,472 - $42,097	-294 Reduced 0.41%	71,295 $9.82 Million
Q1 2024 May 15, 2024	SELL	$130.4 - $143.74 $5.91 Million - $6.52 Million	-45,325 Reduced 38.77%	71,589 $9.87 Million
Q4 2023 Feb 14, 2024	SELL	$106.07 - $132.76 $8.12 Million - $10.2 Million	-76,568 Reduced 39.57%	116,914 $15.4 Million
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $6.22 Million - $7.74 Million	66,129 Added 51.93%	193,482 $21.8 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $5.81 Million - $6.81 Million	-64,924 Reduced 33.77%	127,353 $12 Million
Q1 2023 May 15, 2023	SELL	$94.11 - $123.02 $4.61 Million - $6.03 Million	-48,981 Reduced 20.3%	192,277 $19.5 Million
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $1.99 Million - $2.36 Million	18,601 Added 8.35%	241,258 $28.8 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $11.5 Million - $13.5 Million	124,773 Added 127.47%	222,657 $23.6 Million
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $7.42 Million - $9.8 Million	97,884 New	97,884 $9.54 Million
Q3 2020 Nov 16, 2020	SELL	$96.16 - $135.15 $248,573 - $349,362	-2,585 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $373,460 - $572,150	-4,389 Reduced 62.93%	2,585 $315,000
Q1 2020 May 15, 2020	SELL	$75.11 - $113.76 $970,871 - $1.47 Million	-12,926 Reduced 64.95%	6,974 $604,000
Q4 2019 Feb 12, 2020	SELL	$86.8 - $118.57 $1 Million - $1.37 Million	-11,577 Reduced 36.78%	19,900 $2.14 Million
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $2.64 Million - $3.19 Million	31,477 New	31,477 $2.84 Million
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $1.22 Million - $2.23 Million	-17,893 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $323,238 - $411,403	3,269 Added 22.35%	17,893 $2.2 Million
Q2 2018 Aug 14, 2018	SELL	$75.3 - $105.99 $138,476 - $194,915	-1,839 Reduced 11.17%	14,624 $1.44 Million
Q1 2018 May 15, 2018	BUY	$75.88 - $92.43 $245,623 - $299,195	3,237 Added 24.47%	16,463 $1.37 Million
Q4 2017 Feb 14, 2018	SELL	$58.53 - $77.59 $62,861 - $83,331	-1,074 Reduced 7.51%	13,226 $1.03 Million
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $685,971 - $876,304	14,300	14,300 $876,000

Others Institutions Holding NBIX

# of Institutions

654

Shares Held

96.5M

Call Options Held

282K

Put Options Held

281K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.4B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Account

Driehaus Capital Management LLC Neurocrine Biosciences Inc Transaction History